To investigate whether eosinophils are stimulated in vtvo or have acquired an increased susceptibility to stimuli from the coagulation cascade, the release of eosinophil proteins was compared for three groups of donors with different levels of serum IgE. (1) with atopic dermatitis (s-IgE> 5000 IU/ml, n= 11); (2) with inhalant allergy (200 < s-IgE < 2 000 IU/ml, n 10); and (3) non-allergic (sIgE < 100 IU/ml, n 10). The levels of eosinophil cationic protein and eosinophil protein X (ECP, EPX) were determined in serum (clotting time 2.0 h) and plasma. Serum and plasma ECP in normal donors demonstrated large intra-personal variations (C.V. 50-80%), but serum-ECP (mean 8.1ng/ml) was clearly distinguishable from plasma ECP (mean 1.0 ng/ml) by a factor of 8 (range: 5.6-11.6). The ECP released during clotting was markedly increased in the atopic dermatitis group (serum:plasma ratio 13.5, p < 0.003) compared with the other groups (6.7 and 5.6). EPX, having a higher plasma level, demonstrated a less pronounced release (serum: plasma ratios 2.0, 1.7 and 1.4), with no statistical difference between donor groups. Considering all donors together the levels of ECP and EPX in plasma and in serum were correlated to the number of eosinophils (coefficients of correlation 0.54-0.58, p < 0.002).
Introduction
Increased levels of plasma IgE and accumulation of eosinophils in blood and inflamed tissues are considered to be two important immunological features in allergic disease. 1 2 x 106/ml) in the medium described by Ysse115 at 37C, in a humidified atmosphere containing 5% CO,.. Cells and medium were transferred to new wells at day 2, and the supernatants were harvested at day 11. Control cultures were acid extracted at day 0 as described, 16 and IgE was determined by an immunoradiometric assay (sensitivity 50 pg/ml). To investigate whether the higher serum-to-plasma ratio in the atopic dermatitis group reflected a higher state of activation (analogous to the 'releasability' concept for basophilsTM) or merely a higher number of eosinophils, the amounts of released protein were calculated on a per cell basis. Fig. 2 Regarding the ECP release a marked difference was observed between the atopic dermatitis group and the two other groups (Fig. 1) . It cannot be concluded, however, that this difference stems from different levels of activation. More likely the difference reflects the fact that the release of ECP during the clotting of blood is related only to the number of eosinophils. This is emphasized in Fig. 2 hypodense eosinophils in the blood of the patients, it is also possible that the blood eosinophils have not been activated and that activated eosinophils are located exclusively in the target organ of the inflammatory process.
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